Mark Levin, Partner and Co-Founder of Third Rock Ventures, will deliver a keynote address at the Eighth Annual State of Personalized Medicine Luncheon hosted by the Personalized Medicine Coalition (PMC).

Mr. Levin will bring the venture perspective to the State of Personalized Medicine series and discuss why he continues to invest in personalized medicine.

As co-founder of Third Rock Ventures, Mark Levin focuses on the formation, development and business strategy of portfolio companies, as well as actively identifying and evaluating new investments. He currently serves on a number of boards including Foundation Medicine, Eleven Biotherapeutics, Constellation Pharmaceuticals, DC Devices and NinePoint Medical. Mr. Levin also served as CEO of Millennium Pharmaceuticals for 12 years.

Stafford O'Kelly, President of Molecular Diagnostics at Abbott Molecular and the new Chairman of the PMC Board of Directors, will introduce Mr. Levin.

Previous keynote speakers at the State of Personalized Medicine Luncheon include Mr. John Castellani, President and CEO of PhRMA; Dr. Margaret Hamburg, Commissioner of the Food and Drug Administration; Dr. Denis Cortese, President and CEO of the Mayo Clinic; Dr. Harvey Fineberg, President of the Institute of Medicine; The Honorable Michael O. Leavitt, Secretary of Health and Human Services; Dr. Andrew von Eschenbach, Commissioner of the Food and Drug Administration; and Dr. Francis Collins, Director of the National Human Genome Research Institute.

Pricing:
PMC Members - No Charge
Non-PMC Members - $100
Government and Media - No Charge

Event Sponsor: